Blue Crest Capital Management LTD Fibrogen Inc Transaction History

Blue Crest Capital Management LTD

  • $1.62 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$34.58 - $48.06 $458,461 - $637,179
-13,258 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$36.98 - $48.45 $554 - $726
-15 Reduced 0.11%
13,258 $490,000
Q2 2019

Aug 14, 2019
BUY
$35.13 - $55.53 $466,280 - $737,049
13,273 New
13,273 $600,000

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email